Risk of Arterial Thromboembolism in Patients With Cancer https://t.co/alhw9soTXj https://t.co/gImkJviih6
RT @JACCJournals: Want to earn CME-MOC credit while learning about the risk of arterial thromboembolism in patients with cancer? #JACC http…
Want to earn CME-MOC credit while learning about the risk of arterial thromboembolism in patients with cancer? #JACC https://t.co/ShWmyGjpEv https://t.co/Vx8ePN4ZWX
RT @cuepidemiology: Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind ht…
Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind https://t.co/1B0SSought https://t.co/YZ5PWphGvZ
RT @cuepidemiology: Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind ht…
RT @cuepidemiology: Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind ht…
Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind https://t.co/1B0SSocFpV https://t.co/PKczhrETxe
RT @cuepidemiology: Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind ht…
Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind https://t.co/1B0SSought https://t.co/o1ccpFL7U2
RT @MaryCushmanMD: Very important work! Read it. https://t.co/b9YEs5NIKY
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
Very important work! Read it. https://t.co/b9YEs5NIKY
RT @cuepidemiology: Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind ht…
Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind https://t.co/1B0SSought https://t.co/aEi2eS7cOb
RT @cuepidemiology: Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind ht…
Cancer patients are at increased risk for heart attacks and dangerous blood clots, finds @Columbia’s Mitchell Elkind https://t.co/1B0SSocFpV https://t.co/FccVev0CZV
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @GMahe_: Cancer and risk of arterial #thrombosis : good paper @JACCJournals https://t.co/4E2Tl5AdEx
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @GMahe_: Cancer and risk of arterial #thrombosis : good paper @JACCJournals https://t.co/4E2Tl5AdEx
RT @GMahe_: Cancer and risk of arterial #thrombosis : good paper @JACCJournals https://t.co/4E2Tl5AdEx
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @GMahe_: Cancer and risk of arterial #thrombosis : good paper @JACCJournals https://t.co/4E2Tl5AdEx
Cancer and risk of arterial #thrombosis : good paper @JACCJournals https://t.co/4E2Tl5AdEx
RT @ThrombosisCan: #CAT risk evidence from the Aug 22 issue of JACC: Risk of Arterial Thromboembolism in Patients With Cancer (paid) https:…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @ThrombosisCan: #CAT risk evidence from the Aug 22 issue of JACC: Risk of Arterial Thromboembolism in Patients With Cancer (paid) https:…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @JACCJournals: Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://…
RT @ThrombosisCan: #CAT risk evidence from the Aug 22 issue of JACC: Risk of Arterial Thromboembolism in Patients With Cancer (paid) https:…
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
Should patients with new cancer be started on antithrombotic medications? New research sheds light on risk #JACC https://t.co/oBGf0oW7aT https://t.co/zZpMMcRfxH
RT @JACCJournals: Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC http…
Patients w/ new diagnosis of cancer are @ increased risk for arterial thrombus, especially in the 1st 6 months #JACC https://t.co/VTt8R2sxMM https://t.co/2cf2NqNLLb
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
RT @JACCJournals: What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8…
What is the risk of arterial thromboembolism in cancer patients? Analysis of 279K patients in #JACC https://t.co/dQmd3Rt8Kl https://t.co/RlrQ5lOyVE
RT @ThrombosisCan: #CAT risk evidence from the Aug 22 issue of JACC: Risk of Arterial Thromboembolism in Patients With Cancer (paid) https:…
Patients show an elevated risk for myocardial infarction and ischemic stroke 6 months after cancer diagnosis. https://t.co/LFH3iy1BFh
#CAT risk evidence from the Aug 22 issue of JACC: Risk of Arterial Thromboembolism in Patients With Cancer (paid) https://t.co/5IJIqtu7vW https://t.co/ASBXHma21e
Risk of #stroke is doubled in #cancer patients. Research #collaboration between @WeillCornell and @sloan_kettering. https://t.co/M0WZYYxQ2m
RT @Office_j: 【がん患者30万例追跡:診断後6ヶ月以内のMI発生率は2.0%。対照群 [0.7%] に比べHRは2.9 [95%CI 2.8-3.1]。脳梗塞は.3.0% vs 1.6% [1.9, 1.8-2.0]】 JACC https://t.co/DKS…
【がん患者30万例追跡:診断後6ヶ月以内のMI発生率は2.0%。対照群 [0.7%] に比べHRは2.9 [95%CI 2.8-3.1]。脳梗塞は.3.0% vs 1.6% [1.9, 1.8-2.0]】 JACC https://t.co/DKSzoVFu0z https://t.co/WJTK68VzE9